Prevalencia de sarcopenia en una unidad de media y larga estancia

Maicas, C. Rubio; Duarte-Alfonso, E.; Beseler-Soto, M.R.; Moreno-Muñoz, I.; Moral-Moral, Pedro; Merino-Torres, Juan Francisco

doi:10.1016/j.rce.2014.02.018

Cited by 11 publications

(3 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In relation to the type of elderly population, the prevalence of sarcopenia was higher in elderly people in the rehabilitation units, followed by nursing homes and hospitalized in previous studies [19–21]. Therefore, we excluded these studies that may overestimate its prevalence.…”

Section: Discussionmentioning

confidence: 98%

Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies

Shafiee

Keshtkar

Soltani

et al. 2017

J Diabetes Metab Disord

780

509

View full text Add to dashboard Cite

BackgroundSarcopenia, an age-related decline in muscle mass and function, is one of the most important health problems in elderly with a high rate of adverse outcomes. However, several studies have investigated the prevalence of sarcopenia in the world, the results have been inconsistent. The current systematic review and meta- analysis study was conducted to estimate the overall prevalence of sarcopenia in both genders in different regions of the world.MethodsElectronic databases, including MEDLINE (via PubMed), SCOPUS and Web of Science were searched between January 2009 and December 2016. The population- based studies that reported the prevalence of sarcopenia in healthy adults aged ≥ 60 years using the European Working Group on Sarcopenia in Older People (EWGSOP), the International Working Group on Sarcopenia (IWGS) and Asian Working Group for Sarcopenia (AWGS) definitions, were selected. According to these consensual definitions, sarcopenia was defined by presence of low muscle mass (adjusted appendicular muscle mass for height) and muscle strength (handgrip strength) or physical performance (the usual gait speed).The random effect model was used for estimation the prevalence of sarcopenia. The sex-specific prevalence of sarcopenia and 95% confidence interval (CI) were calculated using the Binomial Exact Method. Heterogeneity was assessed by subgroup analysis.ResultsThirty- five articles met our inclusion criteria, with a total of 58404 individuals. The overall estimates of prevalence was 10% (95% CI: 8-12%) in men and 10% (95% CI: 8-13%) in women, respectively. The prevalence was higher among non- Asian than Asian individuals in both genders especially, when the Bio-electrical Impedance Analysis (BIA) was used to measure muscle mass (19% vs 10% in men; 20% vs 11% in women).ConclusionDespite the differences encountered between the studies, regarding diagnostic tools used to measure of muscle mass and different regions of the world for estimating parameters of sarcopenia, present systematic review revealed that a substantial proportion of the old people has sarcopenia, even in healthy populations. However, sarcopenia is as a consequence of the aging progress, early diagnosis can prevent some adverse outcomes.

show abstract

Section: Discussionmentioning

confidence: 98%

Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies

Shafiee

Keshtkar

Soltani

et al. 2017

J Diabetes Metab Disord

780

509

View full text Add to dashboard Cite

show abstract

“…In relation to the type of elderly population, the prevalence of sarcopenia was higher in elderly people in the rehabilitation units, followed by nursing homes and hospitalized in previous studies [19][20][21]. Therefore, we excluded these studies that may overestimate its prevalence.…”

Section: Discussionmentioning

confidence: 99%

Association between N-Terminal Prohormone Brain Natriuretic Peptide and Decreased Skeletal Muscle Mass in a Healthy Adult Population: A Cross-Sectional Study

Yoo

Kim

et al. 2023

Endocrinol Metab

View full text Add to dashboard Cite

Background: Sarcopenia, an age-related decline in muscle mass and function, is one of the most important health problems in elderly with a high rate of adverse outcomes. However, several studies have investigated the prevalence of sarcopenia in the world, the results have been inconsistent. The current systematic review and meta-analysis study was conducted to estimate the overall prevalence of sarcopenia in both genders in different regions of the world. Methods: Electronic databases, including MEDLINE (via PubMed), SCOPUS and Web of Science were searched between January 2009 and December 2016. The population-based studies that reported the prevalence of sarcopenia in healthy adults aged ≥ 60 years using the European Working Group on Sarcopenia in Older People (EWGSOP), the International Working Group on Sarcopenia (IWGS) and Asian Working Group for Sarcopenia (AWGS) definitions, were selected. According to these consensual definitions, sarcopenia was defined by presence of low muscle mass (adjusted appendicular muscle mass for height) and muscle strength (handgrip strength) or physical performance (the usual gait speed). The random effect model was used for estimation the prevalence of sarcopenia. The sex-specific prevalence of sarcopenia and 95% confidence interval (CI) were calculated using the Binomial Exact Method. Heterogeneity was assessed by subgroup analysis. Results: Thirty-five articles met our inclusion criteria, with a total of 58404 individuals. The overall estimates of prevalence was 10% (95% CI: 8-12%) in men and 10% (95% CI: 8-13%) in women, respectively. The prevalence was higher among non-Asian than Asian individuals in both genders especially, when the Bio-electrical Impedance Analysis (BIA) was used to measure muscle mass (19% vs 10% in men; 20% vs 11% in women). Conclusion: Despite the differences encountered between the studies, regarding diagnostic tools used to measure of muscle mass and different regions of the world for estimating parameters of sarcopenia, present systematic review revealed that a substantial proportion of the old people has sarcopenia, even in healthy populations. However, sarcopenia is as a consequence of the aging progress, early diagnosis can prevent some adverse outcomes.

show abstract

“…Among senior citizens residing in care facilities, the prevalence is higher than among community-dwelling older people. When this population also includes disabled individuals or those hospitalized to undergo rehabilitative care, the prevalence rate even becomes higher (10) . Thus, specifying the prevalence of sarcopenia is difficult because determining the presence of this condition depends on the definition applied and the individual attributes of the study subjects.…”

Section: Epidemiology Of Sarcopeniamentioning

confidence: 99%

Clinical Management of Sarcopenia: Secondary Publication of Geriatrics & Gerontology International 2018;18 S1:1-44

Arai

2020

JMA J

View full text Add to dashboard Cite

In aging societies, sarcopenia is considered to be a significant threat for the elderly and for people with multimorbidities. Although several diagnostic algorithms are currently available, no guidelines are so far available for the prevention and intervention of sarcopenia. Therefore, we decided to publish clinical sarcopenia guidelines by collaboration with the Japanese Association on Sarcopenia and Frailty, the Japan Geriatrics Society, and the National Center for Geriatrics and Gerontology to provide tools for clinical practice. We published a Japanese version in December 2017 and an English version in May 2018. This article is a summary of these clinical sarcopenia guidelines. As the disease code of sarcopenia is available in Japan, these guidelines would be useful for many healthcare professionals and can be used for the prevention of disabilities in the elderly.

show abstract

Prevalencia de sarcopenia en una unidad de media y larga estancia

Cited by 11 publications

References 19 publications

Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies

Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies

Association between N-Terminal Prohormone Brain Natriuretic Peptide and Decreased Skeletal Muscle Mass in a Healthy Adult Population: A Cross-Sectional Study

Clinical Management of Sarcopenia: Secondary Publication of Geriatrics & Gerontology International 2018;18 S1:1-44

Contact Info

Product

Resources

About